The cardiovascular effects of glp-1 receptor agonists

Cardiovascular Therapeutics, 04/26/2012

Ongoing studies are examining the effects of administering GLP–1R agonists to patients at risk of CVD, postangioplasty patients, post–CABG patients, and patients with heart failure. Additional studies should provide meaningful data to determine whether GLP–1R agonists provide unique treatment benefits to patients at risk for or with established CVD.

Print Article Summary Cat 2 CME Report